[Susceptibility of clinical bacterial isolates to aztreonam].
In vitro activities of 7 antimicrobial agents against organisms (474 strains) isolated from patients with various infections in Ehime University Hospital from May to July 1986 were investigated. Summarized results are as follows: 1. Aztreonam (AZT) showed potent activities against Escherichia coli, Citrobacter sp., Klebsiella pneumoniae, Serratia marcescens, Proteus sp., Pseudomonas aeruginosa and Haemophilus influenzae. 2. Antimicrobial activities of AZT were especially superior against Proteus sp. to the third generation cephem antibiotics. 3. Enterobacter sp. seemed more susceptible to AZT than to cephem antibiotics, but minimum inhibitory concentrations of AZT against may isolates of Enterobacter sp. were in wide ranges.
D001398:Aztreonam / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D002954:Citrobacter / Q000187:drug effects; D004754:Enterobacter / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects
D001398:Aztreonam